NAD+
Educational information only — not medical advice. Many listed compounds are not FDA-approved for human use. Consult a licensed clinician before starting, changing, or stopping any protocol.
Overview
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell of the body. It plays a central role in cellular metabolism, acting as a carrier that shuttles electrons during the reactions that turn food into usable energy. Beyond energy production, it is a substrate for enzymes involved in DNA repair and cellular signaling.
Research has commonly reported that NAD+ concentrations decline with age, which has driven interest in strategies to restore them. Much of the human work to date has focused on oral precursors — molecules the body converts into NAD+ — such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN).
NAD+ itself is sometimes administered by injection or IV to bypass digestive breakdown. This approach is popular in wellness settings, but the published clinical evidence base is built largely around precursors rather than injected NAD+, and benefits in humans remain an active area of study.
How it works
NAD+ cycles between two forms, NAD+ and NADH, allowing it to accept and donate electrons in the reactions that generate cellular energy. It is also consumed by enzyme families such as the sirtuins and PARPs, which are studied for their roles in DNA repair, gene regulation, and the cellular stress response.
Because the body cannot store large reserves of NAD+, cells continually recycle and resynthesize it. Supplementation with NAD+ or its precursors is studied for its potential to support this pool. In human trials, oral precursors have been shown to raise circulating NAD+ metabolites, though how reliably that translates into downstream functional effects is not yet established.
Reported benefits
- Studied for supporting cellular energy metabolism (mechanistic and preclinical data)
- Reported use for general vitality and healthy-aging goals
- Investigated for effects on DNA repair and cellular stress pathways
- Explored for cognitive and metabolic endpoints in early clinical trials
These are reported and studied effects, not guaranteed outcomes, and human evidence remains limited.
Considerations & side effects
Oral NAD+ precursors have generally been well tolerated in the human trials conducted so far, with side effects tending to be mild. Data on injected or IV NAD+ specifically is much thinner, and rapid infusions are commonly reported to cause transient discomfort such as flushing, chest tightness, nausea, or lightheadedness.
Long-term safety of NAD+-boosting approaches is not fully characterized, and product quality in the research and supplement markets varies. NAD+ is not a substitute for evaluation and treatment by a qualified clinician.
Frequently asked
What is NAD+?
Nicotinamide adenine dinucleotide is a coenzyme found in every living cell. It is central to how cells convert nutrients into energy and is also involved in DNA repair and cellular signaling.
Is NAD+ FDA-approved?
No. NAD+ and its precursors are not approved by the FDA as drugs. Some precursors are sold as dietary supplements, while injectable NAD+ is offered off-label and is not an approved therapy.
Why do people take NAD+ instead of a precursor pill?
NAD+ levels are commonly reported to decline with age. Injection is used to bypass digestive breakdown, though most published human trials have studied oral precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) rather than injected NAD+ itself.
Is there strong human evidence for anti-aging benefits?
Not yet. Precursor supplements have been shown to raise NAD+ levels in humans, but clear clinical evidence for anti-aging or performance benefits remains limited and is still emerging.
References
- Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. ↗
- Freeberg KA, et al. Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions. ↗
- Song Q, et al. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. ↗
Related compounds
First mitochondria-derived peptide discovered, encoded from mitochondrial DNA. Demonstrates cytoprotective and anti-apoptotic properties with particular relevance for neurological health and longevity.
Mitochondrial-derived peptide that regulates metabolic homeostasis. Enhances exercise capacity, insulin sensitivity, and cellular energy production.
Mitochondria-targeted tetrapeptide that stabilizes cardiolipin in the inner mitochondrial membrane. Reduces oxidative stress and supports cellular energy production.